Animal studies suggest that mTOR inhibitor drugs, such as rapamycin, may aid to lower the AD progression or ameliorate cognitive impairments of AD12, 13; however, based on the data retrieved from clinicaltrial.gov, there is no terminated clinical trial on elucidating the effects of rapamycin on delaying the progression of AD to date. Here, MTOR is linked to Cognitive impairment.